Robert Eisenbach

Cooley advised Brii Biosciences on its agreements with VBI Vaccines (NASDAQ: VBIV) to ensure expansion and control of future clinical and commercial supplies of BRII-179, a late-stage clinical asset in Brii Bio’s hepatitis B virus functional cure portfolio. With operations in major biotechnology centers in the US and China, Brii Bio (HKSE: 2137) is a Hong Kong Stock Exchange-listed biotechnology company developing therapies to improve patient health and choice across diseases with high unmet needs.

Cooley advised Blue Owl Capital, a top asset manager redefining alternatives, on its strategic investment a $300 million royalty financing and a $450 million credit facility in BridgeBio Pharma, a commercial-stage biopharmaceutical company focused on genetic diseases and cancers.

Cooley advised Allorion Therapeutics, a US- and China-based biotechnology company that focuses on the discovery of new small molecule drugs for treating cancer and autoimmune diseases, on its exclusive option and global license agreement with AstraZeneca to develop and commercialize a novel epidermal growth factor receptor (EGFR) L858R mutated allosteric inhibitor as a potential new treatment for advanced EGFR-mutant non-small-cell lung cancer.

Cooley advised Momofuku Goods, a brand of restaurant-grade pantry staples, on its $17.5 million Series A financing led by Siddhi Capital. The new funding will allow Momofuku to expand product offerings and support its growing operations, which includes scaling its team and marketing efforts.

“We spent a decade testing and developing our pantry essentials, ensuring that they were up to the standards we uphold in our restaurants,” David Chang, celebrity chef and founder of Momofuku restaurant group, said in a press statement. “With this investment, I’m looking forward to bringing even more flavor to home cooks’ kitchens.” Founded by the team behind Momofuku restaurants, Momofuku Goods offers a range of products, including chili crunch oil, air-dried noodles, soy sauce, rice vinegar and seasoned salts that are sold online and in more than 2,000 retail stores.

Winston Gu and Yvan-Claude Pierre led the Cooley team, which also included Len Jacoby, JP Oleksiuk, Jonathan Rivinus, Robert Eisenbach, Joyce Kim, Chris Chynoweth, Andrew Mettry, Bomin Kim and Noah Belsky.

Cooley advised GrowFlow, a business-to-business software as a service (SaaS) platform dedicated to helping customers grow their cannabis businesses, on its agreement to sell to Dama Financial, the nation’s largest provider of access to banking and payment solutions for the cannabis industry. Partners Dave Young and Steven Dunst led the Cooley team advising GrowFlow.